Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018553HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10005139HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10017708HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10017489HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10017490HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10005140HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10005141HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10008153HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10008154HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10025297HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TCGA Plot Options
Drug Information
GeneFGA
DrugBank IDDB00009
Drug NameAlteplase
Target IDBE0000538
UniProt IDP02671
Regulation Typebinder
PubMed IDs18673235; 17963464; 22248305
CitationsLongstaff C, Williams S, Thelwell C: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy. Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23.@@Hilleman DE, Tsikouris JP, Seals AA, Marmur JD: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70.@@Acheampong P, Ford GA: Pharmacokinetics of alteplase in the treatment of ischaemic stroke. Expert Opin Drug Metab Toxicol. 2012 Feb;8(2):271-81. doi: 10.1517/17425255.2012.652615. Epub 2012 Jan 17.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
PathwaysAlteplase Action Pathway
PharmGKBPA164776730
ChEMBLCHEMBL1201593